Skip to content
Methylene Blue Pharmacology, Clinical Applications, and Compounding Considerations
Missed the live webinar on November 19, 2025? It’s now available on-demand so you can access the full program whenever it fits your schedule.
Curious about the latest research and clinical uses of Methylene Blue? This program explores its emerging role in treating conditions like Lyme disease, dementia, Alzheimer’s, post-COVID syndrome, and more—plus offers practical compounding tips for pharmacy teams.
This talk aims to illuminate the evolving landscape of Methylene Blue’s applications in healthcare, specifically focusing on its novel utilization for enhancing patient outcomes. It delves into recent advancements and promising research for conditions such as Lyme disease, dementia, bladder health, Alzheimer’s disease, post-COVID syndrome, and anti-aging/nootropic effects.
The program also covers Methylene Blue’s pharmacology, including mechanisms of action, pharmacokinetics, and pharmacodynamics. Learners will outline evidence-based prescribing protocols and dosing strategies and learn to recognize common adverse reactions while reviewing appropriate management strategies for patient safety.
Pharmacists can expect insights into how this versatile compound contributes to improved patient care, supporting a deeper understanding of its potential impact on healthcare outcomes. Practical compounding process tips are included to benefit Pharmacy Technicians and improve lab efficiency.
Learning Objectives for Pharmacists and Pharmacy Technicians:
-
Describe recent advancements and research findings on methylene blue’s effectiveness in managing conditions such as Lyme disease, dementia, bladder health, Alzheimer’s disease, and COVID-19.
-
Recognize the potential anti-aging and nootropic effects of methylene blue and their relationship to cognitive health.
-
Outline the pharmacological profile of methylene blue, including mechanisms of action, pharmacokinetics, and pharmacodynamics.
-
List key prescribing considerations and general dosing strategies for methylene blue in clinical settings.
-
Identify common adverse reactions to methylene blue and recall strategies for promoting patient safety.
-
Identify practical tips and techniques for working with methylene blue in a compounding lab setting that support efficient workflow.
SPECIAL PRICING FOR PHARMACY TECHNICIANS AND STUDENT PHARMACISTS
Q: Who should attend this webinar?
Pharmacy professionals, including clinical pharmacists compounding pharmacists, pharmacy technicians, and other health care professionals interested in methylene blue.
Q: Will I earn CE credit?
Yes. This activity is ACPE-accredited for pharmacists and pharmacy technicians.
Whether you’re looking to deepen your understanding of Methylene Blue’s pharmacology or stay informed on its emerging clinical applications, this on-demand webinar delivers timely, practical insight for pharmacists and pharmacy technicians. Registration is below.
What attendees said:
- “This was a well presented webinar!”
- “Good format, presenter well informed, good information.”
- “Provided an in-depth review of the full drug profile.”
Note: It is not necessary to create a Lecture Panda account to register for this webinar.
Additional On-Demand CE Available
The American College of Apothecaries (ACA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACA has accredited this knowledge-based program for 1 contact hour (0.1 CEU) of continuing education credit for pharmacists and pharmacy technicians.
Register of Historic Places and is world-famous for its five resident Mallard ducks, who march daily through the lobby at 11am and 5pm.
Martha M. Rumore, PharmD, Esq, MS, LLM, FAPhA is a pharmacist-attorney in Frier Levitt’s Life Sciences Department. She is also a registered patent attorney and leads the firm’s Intellectual property team. She has broad and in-depth healthcare and regulatory experience. Her practice focuses on intellectual property (patents, trademarks, copyrights, trade secrets) and healthcare law, Food, Drug, Device & Cosmetic law (all facets-483s to clinical trials to registrations and product approval), pharmacy law and regulatory issues, 503A/503B compounding, Board of Pharmacy (licensing and disciplinary matters), PBM audits, and DSCSA supply chain compliance. Dr. Rumore has over 25 years of health-system, pharmaceutical industry, and law firm experience in the area of Food, Drug & Cosmetic Law, and pharmaceutical intellectual property Dr. Rumore is fluent in cGMPs, GCPs, writing and reviewing Clinical Trial Agreements (CTAs), Investigator brochures, manuscripts, labeling & advertising review, NDAs, study reports, and documents for regulatory submissions. She often prepares legal memoranda on healthcare/FDA matters and conducts Mock State Board of Pharmacy and FDA inspections for compounding pharmacies. Dr. Rumore has practiced both pharmacy and law. She has actual experience as a compounding pharmacist. She regularly counsels on Section 503A and state-specific compounding requirements, assesses compounding practices for state and federal regulatory compliance, including USP 797/795/800, medical necessity documentation, advertising & promotion, reimbursement issues, infrastructure, and preparing compounding policies and procedures that provide clear guidelines, standards, and training for staff. Previously, she was at the Director level in Drug Regulatory Affairs/Compliance in the pharmaceutical industry and hospital pharmacy. She taught Pharmacy Law, Drug Regulatory Affairs, and Food Drug & Cosmetic Law at several New York Colleges of Pharmacy and currently teaches Food, Drug & Cosmetic Law at Maurice A. Deane School of Law at Hofstra University. She is a frequent lecturer and has over 200 publications and presentations.
Dr. Jay Phipps, PharmD, MBA, FACA, FACVP, the pharmacy gladiator, is a pharmacy doctor, entrepreneur, president, and CEO at Phipps Pharmacy. Phipps Pharmacy is an independent pharmacy who provides pharmacy doctor provided patient care including traditional dispensing, compounding services, long-term care pharmacy services, and tailor-made prescription compounding to patients in middle and west Tennessee. Dr. Jay is also the President and CEO of PhippsCare that focuses on Pharmacy Doctor provided healthcare and Health Insurance Solutions which specializes in medical and pharmacy insurance plans for seniors.
